Literature DB >> 3887015

[Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].

H Drexler, A G Truog, H Just, R Zelis.   

Abstract

The present study examined the regional vascular effects (radioactive microspheres) of converting-enzyme inhibition (captopril, 1 mg/kg) and calcium-antagonism (diltiazem, 1 mg/kg) in a rat model of cardiac failure due to large myocardial infarction (n = 18, infarct size 40% of the left ventricle) both at rest and during submaximal treadmill exercise. Diltiazem increased renal, gastrointestinal, coronary and cutaneous blood flow at rest by 29%, 28%, 26% and 37% (p less than 0.05 each) and enhanced skeletal muscle blood flow during exercise by 16% (p less than 0.05). Captopril improved primarily renal and coronary blood flow at rest (by 59% and 23%, respectively, p less than 0.05) and reduced vascular resistance in the gastrointestinal bed by 25% (p less than 0.05) without significant effects in other circulatory beds. We conclude that the regional vascular effects elicited by converting-enzyme inhibition and calcium antagonism differ considerably in this animal model of congestive heart failure and may be clinically important. The favourable regional vascular profile of diltiazem deserves further clinical investigation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887015     DOI: 10.1007/bf01731472

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

Review 1.  Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

2.  Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

Authors:  M A Creager; J L Halperin; D B Bernard; D P Faxon; C D Melidossian; H Gavras; T J Ryan
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

3.  Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rat.

Authors:  S F Flaim; S H Nellis; E J Toggart; H Drexler; K Kanda; E D Newman
Journal:  J Pharmacol Methods       Date:  1984-03

4.  Effects of diltiazem on the cardiocirculatory response to exercise in conscious rat.

Authors:  S F Flaim; J A Annibali; E D Newman; R Zelis
Journal:  J Pharmacol Exp Ther       Date:  1982-12       Impact factor: 4.030

5.  Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.

Authors:  J L Rouleau; K Chatterjee; W Benge; W W Parmley; B Hiramatsu
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

6.  The effects of diltiazem (CRD-401) on the membrane and mechanical properties of vascular smooth muscles of the rabbit.

Authors:  Y Ito; H Kuriyama; H Suzuki
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

7.  Effects of diltiazem Hydrochloride (CRD-401) on renal hemodynamics of dogs.

Authors:  H Ishikawa; M Matsushima; H Matsui; A Honjo; M Hayashi; T Shindo; T Morifuji; M Okaybayashi
Journal:  Arzneimittelforschung       Date:  1978

8.  Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure.

Authors:  J R Wilson; J L Martin; N Ferraro; K T Weber
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

9.  The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.

Authors:  L Watkins; J A Burton; E Haber; J R Cant; F W Smith; A C Barger
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

10.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution.

Authors:  M C Fishbein; D Maclean; P R Maroko
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

View more
  2 in total

1.  Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487.

Authors:  J M Wierda; A M Beaufort; U W Kleef; N J Smeulers; S Agoston
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

Review 2.  The use of angiotensin-converting enzyme inhibitors in congestive heart failure.

Authors:  J L Rouleau; C Juneau; J de Champlain
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.